Igenica is a startup based in the United States, most recent round Series-c-plus.
Igenica is a company headquartered in the United States. Its most recent tracked round is Series-c-plus.
Igenica is a biopharmaceutical company based in Burlingame, California that discovers and develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The company uses patient-based discovery approaches and integrated platforms to identify and prioritize novel oncology targets.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.